If I’d put £25,000 into the FTSE 350 at the start of 2024, here’s how much I’d have today!

Many FTSE shares have rebounded this year as interest rates look set to keep heading lower and market appetite for more risk picks up.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The blue-chip FTSE 100 and mid-cap FTSE 250 are both up year to date. Here, I’ll look at what I’d have now if I’d invested £25k in the FTSE 350 index at the beginning of January.

What is it?

The index in question combines the largest 350 companies listed on the London Stock Exchange, specifically the constituents of the FTSE 100 and FTSE 250.

It offers a broad view of UK corporate performance, spanning diverse sectors like finance, healthcare, energy, and consumer goods. As such, it can be seen as a benchmark for the overall economic health of the UK.

Should you invest £1,000 in AstraZeneca right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if AstraZeneca made the list?

See the 6 stocks

How much?

Unfortunately, the UK economy hasn’t exactly been firing on all cylinders in recent times. Perhaps this is why the FTSE 350 has returned just 30.7% in the past five years, including dividends.

Things have picked up a bit lately though. As of 30 September, the year-to-date total return was approximately 10%. This means that I’d have around £27,500 in my account if I’d invested £25,000 in a tracker like the iShares 350 UK Equity Index Fund.

With inflation falling and more interest rate cuts on the horizon, consumers should have more money to spend. Therefore, I wouldn’t be surprised to see the index inch higher in the coming months.

Buying individual shares

I often look at the S&P 500 — up 200% in 10 years with dividends — and wonder if I should just buy a US tracker, an exchange-traded fund (ETF). It would save me a lot of time researching and following individual shares.

Then again, I’d totally miss out on stocks that can go up 10, 20, or even 50 times in value over time. Personally, I’d rather take on more risk for greater potential reward, at least at this stage.

However, when it comes to FTSE trackers, the meagre historical returns have never tempted me to invest. Instead, I’d rather buy individual UK shares that I think can beat the market.

A true FTSE heavyweight

One stock that I think can carry on outperforming is the FTSE 350’s largest constituent: AstraZeneca (LSE: AZN). Shares of the global pharma giant have returned an annualised 10.2% over the past five years, easily beating the FTSE 100’s 6.1%.

Created with Highcharts 11.4.3AstraZeneca Plc PriceZoom1M3M6MYTD1Y5Y10YALL4 Nov 20194 Nov 2024Zoom ▾Jan '20Jul '20Jan '21Jul '21Jan '22Jul '22Jan '23Jul '23Jan '24Jul '242020202020212021202220222023202320242024www.fool.co.uk

In the first half of 2024, the company’s revenue increased 18% year on year to $25.6bn, driven by double-digit growth across all four divisions. Oncology, its largest unit, grew by an impressive 22%.

One risk I do see here is the new US law requiring drugmakers to negotiate prices with the government’s Medicare health insurance programme (covering 66m people). This could impact future earnings.

Still, I think the stock is set up for further gains. AstraZeneca’s pipeline is massive and it’s aiming to launch 20 new medicines by 2030. It’s targeting $80bn in annual revenue by then, up from $45.8bn in 2023.

Plus, I think accelerating advances in artificial intelligence (AI) could revolutionise the industry. The firm is already “embracing the adoption of responsible AI solutions, from discovery to clinical trials, treatment delivery and beyond to bring the right medicines to the right patients, faster than ever before.”

Finally, AstraZeneca’s forward price-to-earnings multiple of 15.3 looks reasonable to me. I’d buy the stock to hold long term if I didn’t already own it.

Should you buy AstraZeneca shares today?

Before you decide, please take a moment to review this first.

Because my colleague Mark Rogers – The Motley Fool UK’s Director of Investing – has released this special report.

It’s called ‘5 Stocks for Trying to Build Wealth After 50’.

And it’s yours, free.

Of course, the decade ahead looks hazardous. What with inflation recently hitting 40-year highs, a ‘cost of living crisis’ and threat of a new Cold War, knowing where to invest has never been trickier.

And yet, despite the UK stock market recently hitting a new all-time high, Mark and his team think many shares still trade at a substantial discount, offering savvy investors plenty of potential opportunities to strike.

That’s why now could be an ideal time to secure this valuable investment research.

Mark’s ‘Foolish’ analysts have scoured the markets low and high.

This special report reveals 5 of his favourite long-term ‘Buys’.

Please, don’t make any big decisions before seeing them.

Claim your free copy now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Ben McPoland has positions in AstraZeneca Plc. The Motley Fool UK has recommended AstraZeneca Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

artificial intelligence investing algorithms
Investing Articles

Up 272% in just a year, is Palantir stock just getting started?

This writer recognises that Palantir has grown its business very well -- but does the stock price offer him an…

Read more »

Runner standing at the starting point with 2025 year for starting in new year 2025 to achieve business planing and success concept.
Investing Articles

Up 50%? The Aston Martin share price forecast is mind-blowing! 

If analysts are right, the Aston Aston Martin share price could absolutely rocket in the year ahead. Harvey Jones says…

Read more »

Investing Articles

As the S&P 500 drops, here are 2 Stocks and Shares ISA holdings I’m watching

Our writer has different views on how President Trump's tariffs might affect these two US holdings in his Stocks and…

Read more »

Surprised Black girl holding teddy bear toy on Christmas
Investing Articles

£10,000 invested in Tesla stock at Christmas is now worth…

Tesla stock has been one of best-performing investments of the past decade. But things haven't gone to plan for investors…

Read more »

Investing Articles

Up 279% in 5 years, could Meta stock keep soaring?

Meta stock has more than tripled in five years. This writer sees lots to like about the business but also…

Read more »

Pink 3D image of the numbers '2025' growing in size
Investing Articles

25% total return in a year? Is now the perfect time to buy BP shares?

BP shares are on the front line of today's global economic and political uncertainty but analysts think they can still…

Read more »

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

With Cash ISA changes coming, could now be the time to consider buying shares?

Changes to the Cash ISA could lead to greater investment in the stock market. This could be a good thing…

Read more »

Investing Articles

These FTSE 100 dividend shares just got cheaper, thanks to President Trump!

Investors buying dividend shares can lock in bigger long-term yields when share prices take a tumble. These two just did…

Read more »